![Utpal Koppikar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Utpal Koppikar
Direktor/Vorstandsmitglied bei
C4 THERAPEUTICS, INC.
Vermögen: 691 129 $ am 31.10.2026
Profil
Mr. Utpal Koppikar is an Independent Director at Insmed, Inc., a Chief Financial Officer at Verily Life Sciences LLC and an Independent Director at C4 Therapeutics, Inc. He is on the Board of Directors at Insmed, Inc. and C4 Therapeutics, Inc. Mr. Koppikar was previously employed as a Chief Financial Officer & Senior Vice President by Atara Biotherapeutics, Inc. and a Vice President-Corporate & Operations Finance by Gilead Sciences, Inc. He also served on the board at Flexion Therapeutics, Inc. He received his undergraduate degree from the University of Maryland, a graduate degree from Stanford University and an MBA from UCLA Anderson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.10.2026 | 6.139 ( 0 % ) | 691 129 $ | 31.10.2026 | |
| 24.06.2026 | 0 ( -.--% ) | - $ | 31.10.2026 |
Aktive Positionen von Utpal Koppikar
| Unternehmen | Position | Beginn |
|---|---|---|
| C4 THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.03.2022 |
| INSMED INCORPORATED | Direktor/Vorstandsmitglied | 20.10.2026 |
Verily Life Sciences LLC
 Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Finanzdirektor/CFO | 01.04.2023 |
Ehemalige bekannte Positionen von Utpal Koppikar
| Unternehmen | Position | Ende |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 31.03.2023 |
| FLEXION THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.11.2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.06.2018 |
Ausbildung von Utpal Koppikar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
58
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Technology Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
